 |
Title
|
|
|
|
Phase 
|
|
|
|
Protocol
IDs
|
|
|
| |
Chemotherapy Drug Sensitivity Microculture (MiCK) Assay for Apoptosis
|
|
|
|
Phase III, Phase II
|
|
|
|
20050113
NCT00243685
|
|
| |
Testing Drug Sensitivity of Ovarian, Fallopian and Primary Peritoneal Adenocarcinomas
|
|
|
|
Phase III, Phase II
|
|
|
|
WIRB 20060042
NCT00443196
|
|
| |
Pentostatin and Donor White Blood Cells in Preventing Graft Rejection in Cancer Patients Who Have Undergone Donor Stem Cell Transplantation
|
|
|
|
Phase II, Phase I
|
|
|
|
FHCRC-1825.00
5605, SUPERGEN-FHCRC-1825.00, NCT00096161
|
|
| |
Double Cord Blood Transplantation
|
|
|
|
Phase II, Phase I
|
|
|
|
CHNY-06-533
IRB AAAC3457, NCT00801931
|
|
| |
Efficacy of Å6 in Ovarian Cancer Patients Following First-Line Chemotherapy and a Rising CA125 Levels
|
|
|
|
Phase II
|
|
|
|
Å6-003
NCT00083928
|
|
| |
Carboplatin Taxol Avastin in Ovarian Cancer (OVCA)
|
|
|
|
Phase II
|
|
|
|
04-247
NCT00129727
|
|
| |
DOXIL for Consolidation Therapy in Ovarian Cancer.
|
|
|
|
Phase II
|
|
|
|
SEGO_DOXIL_CONS2005
NCT00248248
|
|
| |
Zoledronic Acid in Preventing Osteoporosis in Patients Undergoing Donor Stem Cell Transplant
|
|
|
|
Phase II
|
|
|
|
UMN-2005NT018
UMN-0506M70866, UMN-MT2005-06, NOVARTIS-CZOL446EUS29, NCT00321932
|
|
| |
Tacrolimus and MMF as Post Grafting Immunosuppression After Conditioning With Flu TBI for HLA Matched Family Donor
|
|
|
|
Phase II
|
|
|
|
RMBMT-124-A
NCT00304720
|
|
| |
Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant Ascites
|
|
|
|
Phase II
|
|
|
|
IP-REM-AC-02-US
NCT00326885
|
|
